Loading...
Market
Will long COVID prevalence among U.S. Marines drop below 20% by October 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Follow-up studies or reports published by The Lancet or similar reputable medical journals
Story
Study Reveals 24.7% Long COVID Prevalence in U.S. Marines
Oct 25, 2024, 07:35 PM
Recent studies have revealed that a significant portion of young, healthy U.S. Marines are experiencing long COVID symptoms. According to a study published in The Lancet Regional Health – Americas, 24.7% of the Marines assessed developed post-acute sequelae of SARS-CoV-2 (PASC). The most prevalent symptoms reported were loss of taste or smell (41.6%), shortness of breath (37.6%), and cough (22.8%). These findings underscore the distinct and severe impact of COVID-19 compared to other respiratory infections, with additional burdens including neurological, cognitive, and fatigue symptoms. The high prevalence of long COVID among Marines, with 25% affected, poses significant challenges for their health and operational readiness.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 3% • 25%
3% to 4% • 25%
4% to 5% • 25%
More than 5% • 25%